The National Institute for Health and Care Excellence (NICE) faced "difficult decisions" when it deemed a breast cancer drug which can extend sufferers lives by "up to six months" was too expensive, according to a health expert.
Dr Hilary Jones told Daybreak the £90,000 price tag per patient would have meant taking funds away from other vital services the NHS provides.
More top news
Armed police have taken part in a dramatic training exercise aimed at recreating the chaos of a Paris-style terror attack.
After a remarkably mild November - a notable mild start to the new month.
The Facebook founder revealed the plan as he and wife Priscilla Chan announced the birth of their baby daughter, Max.